Actively Recruiting
Assessment of Healing and Function After Surgical Reconstruction for Neoplasms Involving Bone
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-04-17
300
Participants Needed
5
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the level of function and bone healing in participants who have undergone reconstructive surgery for bone neoplasms, including bone sarcomas. The study focuses on two groups: those receiving bone grafts or artificial devices and those having tumor surgery with regenerative osseous surgery. The purpose is to observe how well participants recover and how their bones heal over a period of three years after surgery. Participants are divided into two groups based on the type of reconstructive surgery they receive: regenerative osseous surgery or other reconstructive surgery for bone neoplasms. After surgery, study visits for post-operative assessments will occur annually starting after the 36-month mark. The study measures recovery and healing using various assessments including participant-reported and clinician-reported outcome scores, functional mobility tests, and imaging studies. During the study, participants will complete questionnaires like the Toronto Extremity Salvage Score and Musculoskeletal Tumor Society Score to report and assess their function and pain levels. Functional tests such as the Timed Get Up and Go Test will be performed, along with diagnostic evaluations like orthogonal radiographs, weight bearing measurements for lower extremities, and range of motion assessments. These evaluations help researchers understand early and mid-term recovery at 1 and 3 years post-surgery. The total duration of participation aligns with a 3-year follow-up period.
CONDITIONS
Brief Title
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing reconstructive surgery for bone neoplasms on the orthopaedic surgery service at MSK
- Current or prior primary neoplasms involving bone structures, including all subtypes
- Diagnosis confirmed by MSK's Department of Pathology through tissue review
- Patients must read and understand English
- Age 4 years or older
You will not qualify if you...
- Patients weighing less than 17 kilograms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years
Participants undergo reconstructive surgery for bone neoplasms and receive immediate post-operative care.
Regular visits during recovery period (exact frequency depends on clinical care)
Duration - From year 3 onward until study completion
Participants receive annual assessments after 3 years from surgery to monitor healing and function.
Annual visits
Trial Site Locations
Total: 5 locations
1
Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up)
Basking Ridge, New Jersey, United States, 07920
Actively Recruiting
2
Memorial Sloan Kettering Monmouth (Consent and Followup)
Middletown, New Jersey, United States, 07748
Actively Recruiting
3
Memorial Sloan Kettering Westchester (Consent and Followup)
Harrison, New York, United States, 10604
Actively Recruiting
4
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10021
Actively Recruiting
5
Memorial Sloan Kettering at Nassau (Consent and Followup)
Uniondale, New York, United States, 11553
Actively Recruiting
Research Team
D
Daniel Prince, MD, MPH
C
Carol Morris, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here